Chronic daily headaches in children
Authors:
- Andrew D. HersheyAHAndrew D. Hershey
- Marielle A. KabboucheMKMarielle A. Kabbouche
- Scott W. PowersSPScott W. Powers
- 1 September 2006
- journal article
- review article
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 10 (5) , 370-376
Abstract
Chronic daily headache (CDH) is increasingly recognized as a problem in pediatrics and tertiary pediatric headache care. It is estimated that up to 4% of the adult population has CDH. Many of these are chronic migraine (CM). The fraction of the pediatric population with CDH appears to be lower, although the prevalence has not been adequately determined. The simplest definition of CDH is more than 15 headache days per month. In the International Classification of Headache Disorders, Second Edition (ICHD-II), several types of CDH have been identified. These criteria have been contrasted with the Silberstein-Lipton criteria, with revisions suggested. The diagnosis of CDH is further complicated and may be initiated by the overuse of analgesic medications (medication overuse headache) and requires the resolution of this issue before a final diagnosis can be established. In children, most CDH appears to have migraine features, although it may not completely meet the ICHD-II criteria for migraine or CM. Evaluation of CDH needs to include a complete history and physical examination to identify any possibility of the secondary headaches or headaches directly attributed to a secondary cause. Treatment and management involve a multidisciplinary approach, including acute therapy for when the headache severity increases (while avoiding medication overuse), preventative therapy to reduce the frequency and impact of the CDH, and biobehavioral therapy to assist with long-term outcome.Keywords
This publication has 76 references indexed in Scilit:
- Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled TrialHeadache: The Journal of Head and Face Pain, 2005
- Recurrent and chronic headaches in children below 6 years of ageThe Journal of Headache and Pain, 2005
- Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled StudyHeadache: The Journal of Head and Face Pain, 2005
- Botulinum Toxin Type A (BOTOX ® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled TrialHeadache: The Journal of Head and Face Pain, 2005
- Chronic Daily Headache: Correlation Between the 2004 and the 1988 International Headache Society Diagnostic CriteriaHeadache: The Journal of Head and Face Pain, 2004
- Comorbidity of Depressive and Anxiety Disorders in Chronic Daily Headache and Its SubtypesHeadache: The Journal of Head and Face Pain, 2000
- Effectiveness of Amitriptyline in the Prophylactic Management of Childhood HeadachesHeadache: The Journal of Head and Face Pain, 2000
- PREVALENCE AND IMPACT OF MIGRAINENeurologic Clinics, 1997
- Subcutaneous Sumatriptan in the Clinical Setting: The First 50 Consecutive Patients With Acute Migraine in a Pediatric Neurology Office PracticeHeadache: The Journal of Head and Face Pain, 1996
- Classification of Daily and Near‐Daily Headaches: Proposed Revisions to the IHS CriteriaHeadache: The Journal of Head and Face Pain, 1994